Corporate & Securities

Debt Financing

Access to capital is paramount to the health of your business. We understand that. Whether it’s as counsel to borrowers or lenders, we have extensive experience assisting our clients with a broad range of debt financing transactions. We take a practical, results-oriented approach and are involved at every stage — from structuring, negotiation, documentation, lien creation, subordination, and related closing matters to counseling clients on the day-to-day implications that their credit documents have on their business activities and decisions.

Quick Facts

  • Substantial experience representing public and private companies in diverse industries (including consumer and retail, clean technology, information technology, life sciences, manufacturing, and health care) in complex, multi-tranche and conventional debt transactions
  • Experience with diverse collateral including intellectual property, aircraft, securities, health care receivables, and real estate
  • Coordinated team approach with tax, regulatory, environmental, mergers and acquisitions, securities, real estate, and restructuring attorneys
  • Debt transactions with an aggregate deal value of over $4 billion since 2013

Areas of Focus

  • Acquisition / leveraged financings
  • Asset-based working capital facilities
  • Convertible debt
  • Credit and liquidity support
  • Cross border financings
  • Loans with warrants or other equity co-investments
  • Mezzanine loans
  • Rule 144A offerings
  • Senior secured credit facilities, syndicated, and single-lender
  • Subordinated debt
  • Swaps and other derivative products
  • Venture debt
  • Workouts, restructurings, and bankruptcy
Sort by: Name  Title  Office

Representative Experience

  • Lead counsel to a national provider of grocery wholesaling and distribution services  in connection with an $800 million syndicated revolving credit facility and $300 million senior secured notes
  • Lead counsel to the US subsidiary of an international manufacturer in connection with a $235 million syndicated revolving credit facility
  • Lead counsel to a large health care system in connection with a $150 million acquisition term loan
  • Lead counsel to a private equity-sponsored health care provider in connection with a $100 million acquisition credit facility involving multiple acquisitions
  • Lead counsel to a pharmaceutical company in connection with a $500 million revolving credit facility